Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

10.9K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of 1- and 2-unit red blood cell transfusions on continuously monitored vital signs: a longitudinal study.

Blood transfusion = Trasfusione del sangue·2026
Same author

Leukaemia Flow Cytometry in Yemen.

International journal of laboratory hematology·2026
Same author

Imaging Flow Cytometry Detection of Cytogenetic Abnormalities in Circulating CD34+ Cells Predicts Leukemic Transformation in Myelofibrosis.

Cytometry. Part A : the journal of the International Society for Analytical Cytology·2026
Same author

Imaging Flow Cytometric Assessment of del(17p) and amp(1q21) in Circulating Plasma Cells of Myeloma Patients.

Current protocols·2026
Same author

Megakaryocyte emperipolesis in myeloproliferative neoplasms: Are neutrophils friends or foes?

Journal of leukocyte biology·2025
Same author

Flow cytometric detection of BCR::ABL1 in T-lymphocytes in chronic myeloid leukaemia.

Pathology·2025
Same journal

Measurement of microinvasive breast carcinoma in the 6th edition WHO Classification: risk of overstaging and clinical implications.

Journal of clinical pathology·2026
Same journal

Development and internal validation of a multifactorial risk model for predicting disease-free survival in oral squamous cell carcinoma.

Journal of clinical pathology·2026
Same journal

HER2-low as a unique subgroup in breast cancer: insights from neoadjuvant chemotherapy response and survival analysis.

Journal of clinical pathology·2026
Same journal

Polyp-forming Dieulafoy lesion of the rectum.

Journal of clinical pathology·2026
Same journal

Defining biochemical, pathological and molecular factors prognostic in terms of disease control and survival in high-grade extremity soft tissue sarcoma: a scoping review.

Journal of clinical pathology·2026
Same journal

MILGDF: a multi-task, instance-level supervised model for oral squamous cell carcinoma integrating local-global attention and dynamic decision fusion.

Journal of clinical pathology·2026
See all related articles

Related Experiment Video

Updated: Mar 24, 2026

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
10:21

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Published on: February 21, 2018

10.6K

TGFα expression in myeloid malignancies.

Simon Kavanagh1, Bob Mirzai1, Kathy Fuller2

  • 1Pathology and Laboratory Medicine, The University of Western Australia, Crawley, Western Australia, Australia PathWest Laboratory Medicine, Nedlands, Western Australia, Australia.

Journal of Clinical Pathology
|March 18, 2016
PubMed
Summary
This summary is machine-generated.

Transforming growth factor alpha (TGFα) is present in myeloid leukaemia blast cells. This finding suggests TGFα can serve as a diagnostic biomarker and potential therapeutic target in haematopathology.

Keywords:
HAEMATO-ONCOLOGYHAEMATOPATHOLOGYIMMUNOHISTOCHEMISTRY

More Related Videos

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

901
Author Spotlight: Advancing the Detection of Low-Frequency Mutations in Cancer Tissues
07:17

Author Spotlight: Advancing the Detection of Low-Frequency Mutations in Cancer Tissues

Published on: August 23, 2024

2.0K

Related Experiment Videos

Last Updated: Mar 24, 2026

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
10:21

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Published on: February 21, 2018

10.6K
Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

901
Author Spotlight: Advancing the Detection of Low-Frequency Mutations in Cancer Tissues
07:17

Author Spotlight: Advancing the Detection of Low-Frequency Mutations in Cancer Tissues

Published on: August 23, 2024

2.0K

Area of Science:

  • Hematology
  • Oncology
  • Molecular Biology

Background:

  • Transforming growth factor alpha (TGFα) is a peptide growth factor found in normal hematopoiesis.
  • TGFα is also expressed in epithelial neoplasms, but its role in hematopoietic malignancies was previously unevaluated.
  • This study investigates TGFα expression in myeloid malignancies.

Purpose of the Study:

  • To evaluate the expression of TGFα in acute and chronic myeloid malignancies.
  • To determine if TGFα can be used as a biomarker for blast cells in diagnostic hematopathology.
  • To explore TGFα as a potential therapeutic target.

Main Methods:

  • Immunohistochemical analysis was employed to assess TGFα expression.
  • The study included 69 normal bone marrow trephines.
  • 157 cases of myeloid malignancy were analyzed.

Main Results:

  • TGFα was expressed in blast cells of acute myeloid leukemia (AML), myelodysplasia, and accelerated/blast phases of chronic myeloid leukemia (CML).
  • Neoplastic cells in acute promyelocytic leukemia showed significantly weaker TGFα expression compared to other AML subtypes.
  • Blast cells in accelerated and blast phases of CML exhibited positive TGFα expression, similar to AML.

Conclusions:

  • TGFα is expressed in neoplastic myeloblasts, indicating its potential as a blast cell biomarker in diagnostic hematopathology.
  • TGFα immunohistochemistry may aid in identifying novel therapeutic targets for myeloid malignancies.
  • The findings highlight the relevance of TGFα in the context of myeloid cancer biology.